Artelo Biosciences
ARTL0.75173.91% ( +0.0283 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Artelo Biosciences(ARTL) the EBIT is -2.689 M (-13.03%);the EPS is -4 (+68.11%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B13.03%
----
----
EPS
-4.002768.11%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf